7 studies found for:    RO5045337
Show Display Options
Rank Status Study
1 Completed A Study of RO5045337 in Patients With Solid Tumors
Condition: Neoplasms
Intervention: Drug: RO5045337
2 Active, not recruiting An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies
Condition: Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute
Intervention: Drug: RO5045337
3 Completed A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: RO5045337;   Drug: doxorubicin
4 Completed A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery
Condition: Sarcoma
Intervention: Drug: RO5045337
5 Completed A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.
Condition: Hematologic Neoplasms
Intervention: Drug: RO5045337
6 Completed A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors
Condition: Neoplasms
Intervention: Drug: RO5045337
7 Completed A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Condition: Myelogenous Leukemia, Acute
Interventions: Drug: RO5045377;   Drug: cytarabine

Indicates status has not been verified in more than two years